| Download this article: |
| View/Open |
File |
Description |
Size |
Format |
View/Open | 1203_Cox_Moxifloxacin-for-tuberculosis-Authors-reply_Lancet-12-177.pdf | Main article | 45Kb | Adobe PDF |
|
| Title: | Moxifloxacin for tuberculosis - Authors' reply. |
| Authors: | Cox, Helen
Ford, Nathan
von Schoen-Angerer, Tido |
| Affiliation: | Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa; University of Cape Town, Cape Town, South Africa; Médecins Sans Frontières Campaign for Access to Essential Medicines, Geneva, Switzerland |
| Citation: | Lancet 2012; 12:177 |
| Publisher: | Elsevier |
| Journal: | The Lancet Infectious Diseases |
| Issue Date: | Mar-2012 |
| URI: | http://hdl.handle.net/10144/220334 |
| DOI: | 10.1016/S1473-3099(12)70015-4 |
| PubMed ID: | 22361421 |
| Additional Links: | http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70015-4/fulltext |
| Type: | Article |
| Language: | en |
| MeSH: | Tuberculosis
Tuberculosis, Multidrug-Resistant |
| ISSN: | 1474-4457 |
| Rights: | Published by Elsevier
Reproduced on this site with permission of Elsevier Ltd. Please see http://www.thelancet.com/journals/laninf for further relevant comment. |
| Appears in topics: | TB
|
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.
Del.icio.us
LinkedIn
Citeulike
Connotea
Facebook
Stumble it!
